SCHEMBL4162397

SCHEMBL4162397

CC(C)(C)c1ccc(CNCCCc2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I3 Q14994 1/20 0.49
KCNH2 Q12809 2/20 0.49
TMEM97 Q5BJF2 2/20 0.49
SIGMAR1 Q99720 4/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
HDAC3 O15379 4/20 0.43
HDAC4 P56524 4/20 0.43
HDAC1 Q13547 4/20 0.43
HDAC7 Q8WUI4 4/20 0.43
HDAC2 Q92769 4/20 0.43
HDAC10 Q969S8 4/20 0.43
HDAC11 Q96DB2 4/20 0.43
HDAC8 Q9BY41 4/20 0.43
HDAC6 Q9UBN7 4/20 0.43
HDAC9 Q9UKV0 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4161721 0.99 CYP1A2 (0.49) NR1I3KCNH2TMEM97SIGMAR1CYP1A2
SCHEMBL3243483 0.91 NR1I3 (0.56) NR1I3KCNH2TMEM97SIGMAR1CYP1A2
Hydrochloric Acid SCHEMBL3950184 0.90 CYP1A2 (0.58) NR1I3KCNH2TMEM97SIGMAR1CYP1A2
SCHEMBL9618249 0.85 CYP1A2 (0.61) SIGMAR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL12521058 0.84 CHRM2 (0.57) KCNH2TMEM97SIGMAR1CYP1A2CYP2C19
SCHEMBL12520868 0.83 CHRM2 (0.57) SIGMAR1CYP1A2CYP2D6CYP2C19HDAC3
SCHEMBL3237536 0.79 SIGMAR1 (0.64) SIGMAR1CA1CA2HDAC3HDAC4
SCHEMBL3276787 0.79 CA1 (0.51) NR1I3KCNH2TMEM97SIGMAR1CYP1A2
SCHEMBL5177620 0.79 CYP1A2 (0.52) NR1I3KCNH2TMEM97SIGMAR1CYP1A2
SCHEMBL3947879 0.79 CA1 (0.51) NR1I3KCNH2TMEM97SIGMAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090171091-A1 COMPOUNDS SUITABLE AS MODULATORS OF HDL CADILA HEALTHCARE LIMITED (IN) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090171091-A1 COMPOUNDS SUITABLE AS MODULATORS OF HDL CETP, APOB, HDLBP NR1I3 110/4885KCNH2 4719/4885TMEM97 1917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.